Casa
asdas

Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor

Por um escritor misterioso

Descrição
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Table 2 from ASAS40 and ASDAS clinical responses in the ABILITY-1
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Recommendations by the Spanish Society of Rheumatology on the Use
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Concurrent Intervention With Exercises and Stabilized Tumor
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Effects of ustekinumab on spondylitis-associated endpoints in TNFi
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Predictors of ASDAS-CRP inactive disease in axial
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
ASDAS Is More Important Than BASDAI in Advanced Ankylosing
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
TNF Inhibitor Therapy, Ankylosing Spondylitis
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Ankylosing spondylitis disease activity score is related to NSAID
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Translating Improvements with Ixekizumab in Clinical Trial
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Treat to Target in Spondyloarthritis: Myth or Reality? - European
de por adulto (o preço varia de acordo com o tamanho do grupo)